Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) primarily indicated for the treatment of HIV-1 infection in patients who have developed resistance to other antiretroviral therapies.… Read more











![Chemical structure of 4-[[6-Amino-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile-d8](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-6-Amino-2-4-cyanophenylamino-4-pyrimidinyloxy-35-dimethylbenzonitrile-d8.png&w=3840&q=75)

























Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) primarily indicated for the treatment of HIV-1 infection in patients who have developed resistance to other antiretroviral therapies. Laboratories specializing in pharmaceutical quality control require reliable reference standards to ensure the safety and efficacy of this medication. Our category for Etravirine includes a comprehensive selection of process-related impurities, degradation products, and synthetic intermediates essential for accurate impurity profiling and analytical method development. Furthermore, we provide stable isotope labelled compounds, which serve as critical internal standards for quantitative analysis in complex matrices. By utilizing these characterized materials, researchers can perform rigorous method validation, stability studies, and genotoxicity assessments. These high-quality reference materials support compliance with rigorous regulatory guidelines, enabling precise identification and quantification of impurities to maintain the integrity of pharmaceutical formulations throughout the product lifecycle.